Insights+: The US FDA New Drug Approvals in October 2021
The US FDA has approved 4 NDAs and 2 BLAs in 2021, leading to treatments for patients and advances in the health care industry The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 61 novel products in 2021 Additionally, last year in 2020, the US FDA …
Insights+: The US FDA New Drug Approvals in October 2021 Read More »